Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-61167

Single-particle
3.55 Å
EMD-61167 Deposition: 15/08/2024
Map released: 12/03/2025
Last modified: 12/03/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-61167

Cryo-EM structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment CAV-C65 (local refinement)

EMD-61167

Single-particle
3.55 Å
EMD-61167 Deposition: 15/08/2024
Map released: 12/03/2025
Last modified: 12/03/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: complex of the SARS-CoV-2 S 6P trimer with the human neutralizing antibody Fab fragment CAV-C65
Fitted models: 9j66

Deposition Authors: Jing X, Chen Y, Gong P
IgA class switching enhances neutralizing potency against SARS-CoV-2 by increased antibody hinge flexibility.
Xu M, Zhang Z, Sun Y, Mai H, Liu S, Liu S, Lv K, Yu F, Wang Y, Yue X, Zhang J, Cai X, Zhao R, Lu H, Liu L, Luo H, Zhao H, Wang Y, Gong P, Chen S, Jing X, Zhao J, Chen YQ
(2025) Antiviral Res , 235 , 106082 - 106082
PUBMED: 39828085
DOI: doi:10.1016/j.antiviral.2025.106082
ISSN: 0166-3542
ASTM: ARSRDR